日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry

新诊断房颤患者的医疗资源利用情况:来自 GARFIELD-AF 注册研究的全球分析

Mantovani, Lorenzo G; Cozzolino, Paolo; Ferrara, Pietro; Virdone, Saverio; Camm, A John; Verheugt, Freek W A; Bassand, Jean-Pierre; Turpie, Alexander G G; Hacke, Werner; Kayani, Gloria; Goldhaber, Samuel Z; Goto, Shinya; Pieper, Karen S; Gersh, Bernard J; Fox, Keith A A; Haas, Sylvia; van Eickels, Martin; Kakkar, Ajay K; On Behalf Of The Garfield-Af Investigators

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

体重指数与新诊断房颤患者预后的关系:GARFIELD-AF研究

Kovac, Mirjana; Mitic, Gorana; Milenkovic, Marija; Basaric, Dusica; Tomic, Branko; Markovic, Olivera; Zdravkovic, Marija; Ignjatovic, Vera; Camm, Christian Fielder; Virdone, Saverio; Goto, Shinya; Bassand, Jean-Pierre; van Eickels, Martin; Haas, Sylvia; Gersh, Bernard J; Pieper, Karen; Fox, Keith A A; Misselwitz, Frank; Turpie, Alexander G G; Goldhaber, Samuel Z; Verheugt, Freek; Camm, John; Kayani, Gloria; Panchenko, Elizaveta; Oh, Seil; Luciardi, Hector Lucas; Sawhney, Jitendra Pal Singh; Connolly, Stuart J; Angchaisuksiri, Pantep; ten Cate, Hugo; Eikelboom, John W; Kakkar, Ajay K

Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry

新诊断房颤患者使用新型口服抗凝药(NOAC)和维生素K拮抗剂(VKA)的出血及相关死亡率:来自GARFIELD-AF注册研究的结果

Bassand, Jean-Pierre; Virdone, Saverio; Badoz, Marc; Verheugt, Freek W A; Camm, A John; Cools, Frank; Fox, Keith A A; Goldhaber, Samuel Z; Goto, Shinya; Haas, Sylvia; Hacke, Werner; Kayani, Gloria; Misselwitz, Frank; Pieper, Karen S; Turpie, Alexander G G; van Eickels, Martin; Kakkar, Ajay K

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

可改变的出血风险因素对接受利伐沙班抗凝治疗的房颤患者发生大出血的影响

Kirchhof, Paulus; Haas, Sylvia; Amarenco, Pierre; Hess, Susanne; Lambelet, Marc; van Eickels, Martin; Turpie, Alexander G G; Camm, A John

Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry

新诊断为房颤合并慢性肾脏病患者的管理和1年预后:来自前瞻性GARFIELD-AF注册研究的结果

Goto, Shinya; Angchaisuksiri, Pantep; Bassand, Jean-Pierre; Camm, A John; Dominguez, Helena; Illingworth, Laura; Gibbs, Harry; Goldhaber, Samuel Z; Goto, Shinichi; Jing, Zhi-Cheng; Haas, Sylvia; Kayani, Gloria; Koretsune, Yukihiro; Lim, Toon Wei; Oh, Seil; Sawhney, Jitendra P S; Turpie, Alexander G G; van Eickels, Martin; Verheugt, Freek W A; Kakkar, Ajay K

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

GARFIELD-AF 注册研究中 28,628 例患者的死亡、中风和出血风险因素:房颤综合管理的理论依据

Bassand, Jean-Pierre; Accetta, Gabriele; Al Mahmeed, Wael; Corbalan, Ramon; Eikelboom, John; Fitzmaurice, David A; Fox, Keith A A; Gao, Haiyan; Goldhaber, Samuel Z; Goto, Shinya; Haas, Sylvia; Kayani, Gloria; Pieper, Karen; Turpie, Alexander G G; van Eickels, Martin; Verheugt, Freek W A; Kakkar, Ajay K

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

接受冠状动脉支架植入术的房颤患者,采用利伐沙班或剂量调整的口服维生素K拮抗剂两种治疗策略后,再次住院情况的比较

Gibson, C Michael; Pinto, Duane S; Chi, Gerald; Arbetter, Douglas; Yee, Megan; Mehran, Roxana; Bode, Christoph; Halperin, Jonathan; Verheugt, Freek W A; Wildgoose, Peter; Burton, Paul; van Eickels, Martin; Korjian, Serge; Daaboul, Yazan; Jain, Purva; Lip, Gregory Y H; Cohen, Marc; Peterson, Eric D; Fox, Keith A A

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

性别对新诊断非瓣膜性房颤患者1年事件发生率的影响:来自GARFIELD-AF注册研究的最新视角

Camm, A John; Accetta, Gabriele; Al Mahmeed, Wael; Ambrosio, Giuseppe; Goldhaber, Samuel Z; Haas, Sylvia; Jansky, Petr; Kayani, Gloria; Misselwitz, Frank; Oh, Seil; Oto, Ali; Raatikainen, Pekka; Steffel, Jan; van Eickels, Martin; Kakkar, Ajay K

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

XALIA研究中癌症患者的亚组分析:利伐沙班与标准抗凝治疗VTE的非干预性研究

Ageno, Walter; Mantovani, Lorenzo G; Haas, Sylvia; Kreutz, Reinhold; Monje, Danja; Schneider, Jonas; van Eickels, Martin; Gebel, Martin; Turpie, Alexander G G

Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial

利伐沙班与标准疗法在选择性房颤复律中的患者治疗满意度和预算影响:X-VeRT试验的事后分析

Hohnloser, Stefan H; Cappato, Riccardo; Ezekowitz, Michael D; Evers, Thomas; Sahin, Kurtulus; Kirchhof, Paulus; Meng, Isabelle Ling; van Eickels, Martin; Camm, A John